SFRP2 Antibody

1. SFRP2 was downregulated in Choriocarcinoma and low expressed SFRP2 could promote migration, invasion, the epithelial-mesenchymal transition phenotype and stemness of Choriocarcinoma cells via Wnt/beta-catenin signaling PMID: 30396168
2. Results show that SFRP2 and SFRP4 typically associate with a poor prognosis of cancer patients concomitant with the expression of genes associated with epithelial-to-mesenchymal transition. SFRP2 and 4 are likely derived from the tumor stroma, and thus tend to increase in tumors as compared to normal tissues. PMID: 28218291
3. The content of the methylated SFRP2 gene in endometrial tissue of patients with hyperplastic processes higher than 20-25% allows relate these women to the risk group of EC development and dictates the need of intensive observation of such patients. PMID: 29949535
4. Findings demonstrated that SFRP2 was downregulated in pituitary corticotroph adenomas. SFRP2 appears to act as a tumor suppressor in Cushing's disease by regulating the activity of the Wnt signaling pathway. PMID: 29620167
5. SFRP2 was down-regulated in the accelerated and blast phase of CML, whereas, the levels of WNT1, WNT3 and WNT5A were up-regulated in the accelerated and blast phase of CML. Overexpression SFRP2 inhibited proliferation, promoted apoptosis and activated the WNT pathway. PMID: 29704505
6. Methylation of SFRP2 gene may promote the invasiveness of non-small cell lung cancer cells through ZEB1 and MMP9 signaling. PMID: 29320940
7. the differences in SFRP2 promotor methylation observed between colorectal cancer (CRC)patients and healthy individuals by both assays were statistically significant (p<0.001). Our findings, although limited by the small sample size, do not support the use of the MSRH assay for CRC screening in stool. PMID: 28777432
8. augments Wnt3a-mediated beta-catenin signalling in dermal papilla cells, especially in beard dermal papilla cells PMID: 26914690
9. SFRP2 methylation is associated with colorectal cancer development. PMID: 26258809
10. TET1 potently inhibited canonical Wnt/beta-catenin signaling by demethylating and upregulating two upstream antagonists of this pathway, SFRP2 and DKK1, which was associated with inhibition of EMT and cancer cell metastasis. PMID: 28851501
11. SFRP2 could bind to locally present Wnt ligands and alter the balance of intracellular Wnt signaling to antagonize the canonical Wnt pathway in stem cells from the apical papilla. PMID: 28794794
12. SFRP2 induction is remarkable in tumor stroma, with transcription mainly modulated by the nuclear factor-kappaB (NF-kappaB) complex, a property shared by several effectors of the DNA damage secretory program. PMID: 26751775
13. down-regulated in ICU-acquired weakness and mice with inflammation-induced muscle atrophy; possibly establishes a positive feedback loop enhancing TGF-beta1-mediated atrophic effects in inflammation-induced atrophy PMID: 27661566
14. epigenetic silencing of Wnt antagonists was associated with gastric carcinogenesis, and concurrent hypermethylation of SFRP2 and DKK2 could be a potential marker for a prognosis of poor overall survival. PMID: 28152305
15. SFRP2 enhances the adipogenic and neurogenic differentiation potentials of stem cells from apical papilla by up-regulating SOX2 and OCT4. PMID: 28244619
16. SFRP2 is not only an agonist of Wnt pathway, but also a cancer promoting protein for lung cancer. PMID: 26323494
17. DKK1 (dickkopf-1) and SFRP2 (secreted frizzled-related protein 2) were the targets of miR-522 in hepatocellular carcinoma PMID: 26960688
18. the demethylation of SFRP2 gene appeared to inhibit nuclear retention of a key Wnt signaling factor, b-catenin, in osteosarcoma (OS) cell lines. Together, these data suggest that SFRP2 may function as an OS invasion suppressor by interfering with Wnt signaling, and the methylation of SFRP2 gene may promote pathogenesis of OS PMID: 26628297
19. SFRP2 hypermethylation is associated with colorectal cancer. PMID: 27221916
20. Silencing KDM2A, a histone demethylase and BCL6 co-repressor, de-repressed SFRP2 transcription by increasing histone H3K4 and H3K36 methylation at the SFRP2 promoter. PMID: 27074224
21. SFRP2 protein plays a role in the ultraviolet rays induced hyperpigmentary disorders. PMID: 26763443
22. age-related increases in sFRP2 augment both angiogenesis and metastasis of melanoma cells PMID: 27042933
23. Patients with Cytogenetically Normal Primary Acute Myeloid Leukemia and high sFRP2 expression had higher incidence of complete remission rate and better overall survival. PMID: 26517501
24. A combination of GATA5 and SFRP2 methylation could be promising as a marker for the detection and diagnosis of colorectal cancers and adenomas. PMID: 25759530
25. The distribution of Sfrp2 (and Sfrp1) in the eye is consistent with the idea that they modulate visual pathfinding and axon guidance. PMID: 25788689
26. These findings suggest that decreased SFRP2 expression is associated with intermediate/poor karyotypes in acute myeloid leukemia PMID: 25197341
27. The role of SFRP2, as a functional tumor suppressor in the development of oral squamous cell carcinoma, is mediated through inhibition of the Wnt signaling pathway. PMID: 25189527
28. Data suggest that overexpression of secreted frizzled-related protein 2 (sFRP2) gene in mesenchymal stem cells (hMSCs) might improve the therapeutic effectiveness of hMSC transplantation. PMID: 25245632
29. Aberrant methylation of APC gene was statistically significant associated with age over 50, DDK3 with male, SFRP4, WIF1, and WNT5a with increasing tumor stage SFRP4 and WIF1 with tumor differentiation and SFRP2 and SFRP5 with histological type PMID: 25107489
30. In hepatitis C virus infected liver tissues hypermethylation at promoter regions of key cancer related genes SFRP2 and DKK1, appears early at chronic hepatitis and liver cirrhosis stages, long before the appearance of hepatocellular carcinoma. PMID: 24947038
31. High SFRP2 gene methylation is associated with ovarian cancer infected with high risk human papillomavirus. PMID: 24761891
32. The risk size of SFRP2 hypermethylation from normal control to adenoma or polyp as well as from adenoma or polyp to colorectal cancer increased gradually PMID: 25053594
33. results show that sFRP-2 is a target gene of hypermethylation in esophageal Basaloid squamous cell carcinoma PMID: 24464051
34. SFRP2 appears to interact with Slug to affect the apoptosis of hypertrophic scar fibroblasts PMID: 23226515
35. show that SFRP2 hypermethylation is a common event in prostate cancer. SFRP2 methylation in combination with other epigenetic markers may be a useful biomarker of prostate cancer PMID: 22915211
36. Promoter hypermethylation of tumor suppressor SFRP2 is associated with prostate carcinoma. PMID: 22136354
37. Recombinant sFRP2 enhanced Wnt3a-dependent phosphorylation of LRP6 as well as both cytosolic beta-catenin levels and its nuclear translocation. sFRP2 enhanced the Wnt3a-mediated transcription of several genes including DKK1 and NKD1. PMID: 20723538
38. Data suggest that silencing of secreted frizzled-related protein 2 expression through promoter hypermethylation may be a factor in ESCC carcinogenesis through loss of its tumor-suppressive activity. PMID: 22363119
39. there is a loss of SFRP-2 expression from benign to malignant prostate glands and differential SFRP-2 expression among two possible subgroups of Gleason grade 5 tumours PMID: 22175903
40. Hypermethylation of SFRP2 gene is associated with advanced gastric cancer. PMID: 21409489
41. SFRP2 may play an important role in the development of earlobe keloid, especially at the keloid edge. PMID: 21174795
42. A study evaluating the pattern of SFRP2 methylation throughout the promoter during progressive tumorigenesis. PMID: 21709714
43. Among the extracellular regulators that suppress the Wnt pathway, secreted frizzled-related protein 2 (SFRP2), was up-regulated 4.3-fold in healthy smokers and 4.9-fold in COPD smokers. PMID: 21490961
44. serum SFRP2 methylation status represents a promising, non-invasive marker for colorectal carcinoma detection and staging PMID: 21463549
45. Combined effects of epigenetic alterations in SFRP2 and point mutations in K-ras protein play a role in development of mucinous type anal adenocarcinoma. PMID: 20686305
46. Promoter hypermethylation of SFRP2 is associated with Acute myeloid leukemia. PMID: 20795789
47. SFRP2 promoter methylation is aberrant in mesothelioma. PMID: 20596629
48. induces transient rise of intracellular Ca2+ via emptying of intracellular calcium stores in neutrophils PMID: 20602801
49. These results support sFRP2's role as an enhancer of Wnt3A/beta-catenin signaling, a result with biological impact for both normal development and diverse pathologies such as tumorigenesis. PMID: 20723538
50. This is the first report documenting that sFRP2 activates the canonical Wnt pathway and promotes cell growth by evoking diverse signaling cascades in renal cancer cells. PMID: 20501806

显示更多

收起更多

HGNC: 10777

OMIM: 604157

KEGG: hsa:6423

STRING: 9606.ENSP00000274063

UniGene: Hs.481022